Skip to content

Insider · CIK 0001614740

Christopher Peetz

ceoofficerdirector

Files at MIRM (Mirum Pharmaceuticals, Inc.). First filing Sep 3, 2026, latest Sep 3, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $3.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MIRM: Mirum Pharmaceuticals, Inc.

MIRMOct 9, 2026 · close 86.01

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
MIRMsell 310b5-1
Mirum Pharmaceuticals, Inc.
$3.0M
30,000 shares
-13%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Common Stock
+5,305$19.19$102k199,7456 d ago
Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Common Stock
+6,892$15.87$109k206,6376 d ago
Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-5,305$0.00$0169,6956 d ago
Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative
-6,892$0.00$0233,1086 d ago
Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Common Stock10b5-1
+30,000$2.94$88k224,44039 d ago
Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-8,312$98.08$815k216,12839 d ago
Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
SOpen-market sale
Common Stock10b5-1
-21,688$98.91$2.1M194,44039 d ago
Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-30,000$0.00$058,48739 d ago
Nov 8, 2024MIRM
Mirum Pharmaceuticals, Inc.
AGrant or award
Common Stock
+65$21.05$1,368126,848Nov 14, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher Peetz: insider trades and track record | InsiderTell